IPO Premiums
IPO calendar
TCTATVAListed

Tatva Chintan Pharma Chem Limited

Bookbuilding IPO · NSE, BSE

Price band
₹1073-₹1083
Lot size
13 shares
Issue amount
₹500 cr
Total subscription
0×
Current price₹1,903.4
Listing price ₹2,111.85
Watch live price ↗
Opens
16 Jul 2021
Closes
20 Jul 2021
Allotment
26 Jul 2021
Listing
29 Jul 2021

Offer at a glance

Issue overview

Issue size
46,16,804 shares
Face value
₹10 per share
Minimum investment
₹13,949
Fresh issue
₹225 cr
Offer for sale
₹275 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,079
Issue type
Bookbuilding IPO
Shares before issue
2,00,87,500
Shares after issue
2,21,65,062

Lot sizes

CategoryLotsSharesAmount
RETAIL113₹14,079
sHNI15195₹2,11,185
bHNI72936₹10,13,688

Share reservation

QIB50%
Anchor30%
NII (HNI)15%
RETAIL35%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

05551,11023 Dec: ₹1,110
23 Dec₹1,11023 Dec

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
01,0002,0003,0004,000Mar-19 · Revenue: 2,068.01Mar-19 · Profit after tax: 205.43Mar-19Mar-20 · Revenue: 2,646.22Mar-20 · Profit after tax: 377.89Mar-20Mar-21 · Revenue: 3,062.92Mar-21 · Profit after tax: 522.62Mar-21
RevenueProfit after tax

Company information

Company profile

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.

Strengths

  • Leading Manufacturer: Specializes in structure directing agents and phase transfer catalysts.
  • Diversified Portfolio: Offers a wide range of products.
  • Global Presence: Serves customers across industries worldwide.
  • Strategic Location: Gujarat facility near Hazira Port for easy logistics.
  • Experienced Leadership: Promoters supported by a skilled management team.
  • Strong Financials: Consistent track record of solid financial performance.

Promoters

Ajaykumar Mansukhalal Patel

Chintan Nitinkumar Shah

Shekhar Rasiklal Somani

Registrar & documents

Lead manager

ICICI Securities Limited, Jm Financial Limited

Registered office

Plot No. 502 / 17, GIDC Estate, Ankleshwar, Bharuch, Gujarat - 393002, India

+91 75730 46951

[email protected]Company website ↗

Understanding TATVA IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.